FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 316:1062-1068 April 23, 1987 Number 17 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

Between January 1982 and December 1986, among the 750 patients with the acquired immunodeficiency syndrome (AIDS) who were treated at two adjacent hospitals in New York City, 78 (10.4 percent) needed evaluation for renal disorders. Reversible acute renal failure due to nephrotoxic injury, ischemic injury, or both was present in 23 patients (30 percent) (Group I). The remaining 55 (70 percent) had massive proteinuria, azotemia, or both (AIDS-associated nephropathy; Group II), and irreversible uremia developed in 43. In an additional 18 patients, all of whom had a history of intravenous narcotic drug use, AIDS was diagnosed after the initiation of maintenance hemodialysis for chronic renal failure (Group III). Survival for more than six months after the onset of chronic uremia occurred in only two subjects in Group II; all patients in Group III died within three months of the diagnosis of AIDS. Death in the patients in Groups II and III followed a syndrome of "failure to thrive" characterized by inanition unresponsive to intensive nutritional support and hemodialysis. In contrast, 8 of 17 patients with acute renal failure (Group I) and a serum creatinine concentration above 6 mg per deciliter regained renal function (serum creatinine level, less than 2.0 mg per deciliter). Four of the seven lived for 10 to 24 months, whereas the other four died of sepsis within a month. Our observations suggest that maintenance hemodialysis is not effective in prolonging life either in patients with AIDS-associated nephropathy and uremia or in patients with end-stage renal failure in whom AIDS develops during the course of maintenance dialysis. Hemodialysis may be useful in the management of potentially reversible acute renal failure in patients with AIDS.

This article has been cited by other articles:

• Rosenstiel, P., Gharavi, A., D'Agati, V., Klotman, P. (2009). Transgenic and Infectious Animal Models of HIV-Associated Nephropathy. J. Am. Soc. Nephrol. 20: 2296-2304 [Abstract] [Full Text]  
• Yalavarthy, R, Smith, M L, Edelstein, C L (2008). HIV-associated nephropathy in Caucasians: case report and review of literature. Int J STD AIDS 19: 789-790 [Abstract] [Full Text]  
• Lu, T.-c., He, J. C., Wang, Z.-h., Feng, X., Fukumi-Tominaga, T., Chen, N., Xu, J., Iyengar, R., Klotman, P. E. (2008). HIV-1 Nef Disrupts the Podocyte Actin Cytoskeleton by Interacting with Diaphanous Interacting Protein. J. Biol. Chem. 283: 8173-8182 [Abstract] [Full Text]  
• Izzedine, H., Baumelou, A., Deray, G. (2007). Acute renal failure in HIV patients. Nephrol Dial Transplant 22: 2757-2762 [Full Text]  
• Cohen, S. D., Kimmel, P. L. (2007). HIV-associated renal diseases in Africa a desperate need for additional study. Nephrol Dial Transplant 22: 2116-2119 [Full Text]  
• Roland, M. E., Lo, B., Braff, J., Stock, P. G. (2003). Key Clinical, Ethical, and Policy Issues in the Evaluation of the Safety and Effectiveness of Solid Organ Transplantation in HIV-Infected Patients. Arch Intern Med 163: 1773-1778 [Full Text]  
• Kimmel, P. L., Barisoni, L., Kopp, J. B. (2003). Pathogenesis and Treatment of HIV-Associated Renal Diseases: Lessons from Clinical and Animal Studies, Molecular Pathologic Correlations, and Genetic Investigations. ANN INTERN MED 139: 214-226 [Abstract] [Full Text]  
• Rodriguez, R. A., Mendelson, M., O'Hare, A. M., Hsu, L. C., Schoenfeld, P. (2003). Determinants of Survival among HIV-Infected Chronic Dialysis Patients. J. Am. Soc. Nephrol. 14: 1307-1313 [Abstract] [Full Text]  
• Hochegger, K., Mayer, G. J., Rosenkranz, A. R. (2003). Is HIV infection a contraindication for kidney transplantation?. Nephrol Dial Transplant 18: 217-218 [Full Text]  
• Bohjanen, P. R., Johnson, M. D., Szczech, L. A., Wray, D. W., Petros, W. P., Miller, C. R., Hicks, C. B. (2002). Steady-State Pharmacokinetics of Lamivudine in Human Immunodeficiency Virus-Infected Patients with End-Stage Renal Disease Receiving Chronic Dialysis. Antimicrob. Agents Chemother. 46: 2387-2392 [Abstract] [Full Text]  
• Ahuja, T. S., Grady, J., Khan, S. (2002). Changing Trends in the Survival of Dialysis Patients with Human Immunodeficiency Virus in the United States. J. Am. Soc. Nephrol. 13: 1889-1893 [Abstract] [Full Text]  
• Alarcon-Zurita, A., Salas, A., Anton, E., Morey, A., Munar, M. A., Losada, P., Martinez, J. (2000). Membranous glomerulonephritis with nephrotic syndrome in a HIV positive patient--remarkable remission with triple therapy. Nephrol Dial Transplant 15: 1097-1098 [Full Text]  
• Viani, R. M., Dankner, W. M., Muelenaer, P. A., Spector, S. A. (1999). Resolution of HIV-Associated Nephrotic Syndrome With Highly Active Antiretroviral Therapy Delivered by Gastrostomy Tube. Pediatrics 104: 1394-1396 [Abstract] [Full Text]  
• Ifudu, O. (1998). Care of Patients Undergoing Hemodialysis. NEJM 339: 1054-1062 [Full Text]  
• (1996). The Spectrum of HIV-Associated Renal Disease. AIDS Clin Care 1996: 1-1 [Full Text]  
• Kimmel, P. L., VedBrat, S. S., Pierce, P. F., Umana, W. O., Shepherd, L., Verme, D. A., Hirsch, R. P., Hellman, K. B. (1995). Prevalence of Viremia in Human Immunodeficiency Virus-Infected Patients With Renal Disease. Arch Intern Med 155: 1578-1584 [Abstract]  
• Hanson, D. L., Chu, S. Y., Farizo, K. M., Ward, J. W., Adult and Adolescent Spectrum of HIV Disease Proje, (1995). Distribution of CD4+ T Lymphocytes at Diagnosis of Acquired Immunodeficiency Syndrome--Defining and Other Human Immunodeficiency Virus--Related Illnesses. Arch Intern Med 155: 1537-1542 [Abstract]  
• Rolston, K. V. I., Rubenstein, E. B. (1995). Acute Renal Failure Attributable to Ciprofloxacin in a Patient With the Acquired Immunodeficiency Syndrome-Reply. Arch Intern Med 155: 114-115 [Abstract]  
• O'Connor, P. G., Selwyn, P. A., Schottenfeld, R. S. (1994). Medical Care for Injection-Drug Users with Human Immunodeficiency Virus Infection. NEJM 331: 450-459 [Full Text]  
• Cantor, E. S., Kimmel, P. L., Bosch, J. P. (1991). Effect of Race on Expression of Acquired Immunodeficiency Syndrome-Associated Nephropathy. Arch Intern Med 151: 125-128 [Abstract]  
• Appel, R. G., Neill, J. (1990). A Steroid-Responsive Nephrotic Syndrome in a Patient with Human Immunodeficiency Virus (HIV) Infection. ANN INTERN MED 113: 892-893 [Abstract]  
• HUMPHREYS, M. H. (1990). Human Immunodeficiency Virus-Associated Nephropathy: East Is East and West Is West?. Arch Intern Med 150: 253-255 [Abstract]  
• Langs, C., Gallo, G. R., Schacht, R. G., Sidhu, G., Baldwin, D. S. (1990). Rapid Renal Failure in AIDS-Associated Focal Glomerulosclerosis. Arch Intern Med 150: 287-292 [Abstract]  
• Glassock, R. J., Cohen, A. H., Danovitch, G., Parsa, K. P. (1990). Human Immunodeficiency Virus (HIV) Infection and the Kidney. ANN INTERN MED 112: 35-49 [Abstract]  
• Stoneburner, R., Des Jarlais, D., Benezra, D, Gorelkin, L, Sotheran, J., Friedman, SR, Schultz, S, Marmor, M, Mildvan, D, Maslansky, R (1988). A larger spectrum of severe HIV-1--related disease in intravenous drug users in New York City. Science 242: 916-919 [Abstract]